Arvinas Inc (ARVN)
31.38
-0.22
(-0.71%)
USD |
NASDAQ |
Apr 26, 10:10
Arvinas Total Assets (Quarterly): 1.305B for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.305B |
| September 30, 2023 | 1.058B |
| June 30, 2023 | 1.084B |
| March 31, 2023 | 1.176B |
| December 31, 2022 | 1.269B |
| September 30, 2022 | 1.335B |
| June 30, 2022 | 1.407B |
| March 31, 2022 | 1.488B |
| December 31, 2021 | 1.582B |
| September 30, 2021 | 1.605B |
| June 30, 2021 | 644.03M |
| March 31, 2021 | 681.77M |
| Date | Value |
|---|---|
| December 31, 2020 | 717.40M |
| September 30, 2020 | 271.95M |
| June 30, 2020 | 262.58M |
| March 31, 2020 | 282.45M |
| December 31, 2019 | 301.64M |
| September 30, 2019 | 209.09M |
| June 30, 2019 | 172.05M |
| March 31, 2019 | 186.57M |
| December 31, 2018 | 199.28M |
| September 30, 2018 | 98.89M |
| June 30, 2018 | 105.99M |
| December 31, 2017 | 66.85M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
172.05M
Minimum
Jun 2019
1.605B
Maximum
Sep 2021
886.87M
Average
1.058B
Median
Sep 2023
Total Assets (Quarterly) Benchmarks
| Pfizer Inc | 226.50B |
| Bristol-Myers Squibb Co | 95.16B |
| Janux Therapeutics Inc | 380.41M |
| Geron Corp | 394.08M |
| Verastem Inc | 149.72M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 644.60M |
| Shareholders Equity (Quarterly) | 660.00M |
| Debt to Equity Ratio | 0.0012 |
| Current Ratio | 4.979 |
| Net Debt Paydown Yield | 0.00% |